A sofosbuvir-based quadruple regimen is highly effective in HCV type 4-infected Egyptian patients with DAA treatment failure. [electronic resource]
Producer: 20190916Description: 1313-1315 p. digitalISSN:- 1600-0641
- Adult
- Antiviral Agents -- administration & dosage
- Carbamates
- Cohort Studies
- Drug Resistance, Multiple, Viral
- Drug Therapy, Combination
- Egypt
- Female
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Male
- Middle Aged
- Pyrrolidines
- Ribavirin -- administration & dosage
- Simeprevir -- administration & dosage
- Sofosbuvir -- administration & dosage
- Sustained Virologic Response
- Treatment Failure
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Letter; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.